GlaxoSmithKline PLC — Director's Dealing 2015

Jan 5, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3021B

GlaxoSmithKline PLC

05 January 2015

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.84 per Ordinary Share, and notional ADSs at a price of $42.91 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2014 to 31 December 2014:

Non Executive Director	Ordinary Shares	No. of ADSs
Sir Christopher Gent	4,515.896
Professor Sir Roy Anderson	519.328
Dr Stephanie Burns		683.943
Stacey Cartwright	383.851
Lynn  Elsenhans		1,231.098
Judy Lewent		530.646
Sir Deryck Maughan		1,367.886
Dr Daniel Podolsky		1,238.173
Tom de Swaan	474.169
Jing Ulrich		341.972
Hans Wijers	383.851

The Company and the Non-Executive Directors were informed of these allocations on 5 January 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

5 January 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZELFBEFFLBBZ